Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMICQWN)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID; (2-METHYL-5-PHENYL-2H-PYRAZOL-3-YL)-SULFAMIC ACID; UN3; AC1NS1QY; SULFAMIC ACID Analog 13; BDBM13529; DB04800; (2-methyl-5-phenylpyrazol-3-yl)sulfamic acid; N-(2-methyl-5-phenylpyrazol-3-yl)sulfamic acid; (1-methyl-3-phenyl-1H-pyrazol-5-yl)sulfamic acid; N-(1-methyl-3-phenyl-1H-pyrazol-5-yl)sulfamic acid
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||